Dec 1 (Reuters) - Bionomics Ltd (BNO) :
- U.S. FDA GRANTED FAST TRACK DESIGNATION TO BNC210 DEVELOPMENT PROGRAM FOR ACUTE TREATMENT OF SOCIAL ANXIETY DISORDER
News: BNO Bionomics Ltd Says U.S. FDA Granted Fast Track Designation To BNC210 Development Program
Add to My Watchlist
What is My Watchlist?